Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Novartis AG

NVS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$NVS is featured in our Shelley Moore Capito strategy.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NVS by members of U.S. Congress

Politician Type Traded
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 31, 2026
Alan Armstrong Senate / R Purchase $15,001 - $50,000 Mar 30, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 13, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 13, 2026
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Sep 25, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Sep 11, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Jul 22, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 17, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 11, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Jun 10, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 09, 2025
George Whitesides House / D Sale $100,001 - $250,000 Mar 24, 2025
Sheldon Whitehouse Senate / D Sale (Partial) $1,001 - $15,000 Apr 09, 2024
Ro Khanna House / D Exchange None Mar 05, 2024
Sheldon Whitehouse Senate / D Purchase $15,001 - $50,000 Sep 20, 2023
Daniel S. Goldman House / D Sale $50,001 - $100,000 Jul 10, 2023
Thomas R. Carper Senate / D Purchase $1,001 - $15,000 Apr 26, 2023
Daniel S. Goldman House / D Purchase $50,001 - $100,000 Mar 31, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Feb 27, 2023
Ro Khanna House / D Purchase $15,001 - $50,000 Feb 10, 2023
Kevin Hern House / R Sale $1,001 - $15,000 Jan 31, 2023
John H. Rutherford House / R Sale $1,001 - $15,000 Mar 16, 2022
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Feb 28, 2022
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan 27, 2022
Ro Khanna House / D Sale $15,001 - $50,000 Jan 11, 2022
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Dec 22, 2021
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Dec 15, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Sep 17, 2021
Alan S. Lowenthal House / D Sale $15,001 - $50,000 Nov 23, 2020
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Nov 23, 2020
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Nov 23, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov 17, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Oct 05, 2020
Kevin Hern House / R Purchase $1,001 - $15,000 Jul 27, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May 07, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May 04, 2020
Greg Gianforte House / R Purchase $1,001 - $15,000 Mar 18, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 Feb 20, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Feb 14, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan 14, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec 26, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec 10, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov 26, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov 19, 2019
Mikie Sherrill House / D Sale $1,001 - $15,000 May 28, 2019
NVS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NVS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NVS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NVS holdings by institutional investors

Quarterly net insider trading by NVS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $40,000 Feb 04, 2003 Issue: Agriculture

Former government officials who have lobbied for NVS

108 former government officials from 68 congressional offices at 18 lobbying firms have lobbied for NVS, most recently Jul 21, 2026.

  • Jennifer Young Congress Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Raissa Downs Senate Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte. Formerly HELP Cmte. · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Tom Harkin
    Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun Formerly with Tom Harkin · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Emily Murry House Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price Formerly Ken Calvert · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Kyrsten Sinema
    Margaret Joseph Senate CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. Formerly with Kyrsten Sinema · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
  • Peter Fise Congress Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform Formerly Cmte on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 21, 2026
See all 108 on the Revolving Door dashboard

NVS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NVS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NVS Income Statement
NVS Balance Sheet
NVS Cash Flow
U.S. Patents

New NVS patent grants

  • Patent Title: Nucleic acid molecules encoding chimeric antigen receptors comprising a cd20 binding domain Feb. 27, 2024
  • Patent Title: Mammalian expression vector Dec. 27, 2022
  • Patent Title: Container for pharmaceuticals Aug. 02, 2022
  • Patent Title: Container for pharmaceuticals Aug. 02, 2022
  • Patent Title: Glycoside derivatives and uses thereof May. 24, 2022
  • Patent Title: Cell culture medium Dec. 28, 2021
  • Patent Title: Display screen with graphical user interface Nov. 23, 2021
  • Patent Title: Injection device Aug. 24, 2021
  • Patent Title: Injection device Aug. 24, 2021
  • Patent Title: Injection device Aug. 24, 2021
  • Patent Title: Injection device Aug. 24, 2021
  • Patent Title: Display screen with graphical user interface Jun. 15, 2021
  • Patent Title: Display screen with graphical user interface Jun. 15, 2021
  • Patent Title: Display screen with graphical user interface Jun. 15, 2021
  • Patent Title: Packaging box Feb. 16, 2021
  • Patent Title: Packaging box Feb. 09, 2021
  • Patent Title: Methods of treating cancer with low density lipoprotein-related protein 6 (lrp6)—half life extender constructs Feb. 18, 2020
  • Patent Title: Contact lens Dec. 10, 2019
  • Patent Title: Injector and insert for an injector Mar. 19, 2019
  • Patent Title: Intraocular lens delivery device Feb. 19, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Auto-injector Jan. 29, 2019
  • Patent Title: Container for pharmaceuticals Nov. 06, 2018
  • Patent Title: Contact lens Oct. 02, 2018
  • Patent Title: Contact lens Sep. 25, 2018
  • Patent Title: Contact lens Sep. 25, 2018
  • Patent Title: Contact lens Sep. 25, 2018
  • Patent Title: Contact lens Aug. 07, 2018
  • Patent Title: Contact lens Jul. 31, 2018
  • Patent Title: Contact lens Jul. 31, 2018
  • Patent Title: 4-piperidinyl compounds for use as tankyrase inhibitors Jul. 10, 2018
  • Patent Title: Methods for producing vaccine adjuvants Jun. 26, 2018
  • Patent Title: Packaging box Jun. 19, 2018
  • Patent Title: Pyridine and pyrazine derivative for the treatment of cf Mar. 20, 2018
  • Patent Title: Circulation of components during homogenization of emulsions Jun. 20, 2017
  • Patent Title: Pupil expander May. 17, 2016
  • Patent Title: Pupil expander May. 17, 2016
  • Patent Title: Extended depth of focus (edof) lens to increase pseudo-accommodation by utilizing pupil dynamics Apr. 12, 2016
  • Patent Title: Dosing card for a topical preparation Feb. 02, 2016
  • Patent Title: Container for storage Dec. 08, 2015
  • Patent Title: Inhibitors of cyp 17 Sep. 30, 2014
  • Patent Title: Vaccines for protecting against influenza Sep. 03, 2013
  • Patent Title: Vaccines for protecting against influenza Sep. 03, 2013
  • Patent Title: Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use Jan. 15, 2013
  • Patent Title: Powder filling apparatus and methods for their use Nov. 22, 2011
  • Patent Title: Pharmaceutical compositions Dec. 28, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NVS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NVS News

Recent insights relating to NVS

CNBC Recommendations

Recent picks made for NVS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVS

NVS Analyst Ratings

NVS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NVS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NVS stock a Buy, Sell, or Hold?

  • What is the price target for $NVS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NVS Top Shareholders
Shareholder
Shares Held
NVS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NVS stock?

  • Who owns the most shares of $NVS stock?

  • What funds own $NVS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NVS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NVS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NVS

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Novartis AG (NVS) Historical Stock Prices

Novartis AG (NVS) closed at $141.28 on September 22, 2026. Over the past year its adjusted close ranged from $119.42 to $165.33. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-11.07%
  • 3 months-7.89%
  • Year to date+4.51%
  • 1 year+16.81%
  • 3 years+61.57%
  • 5 years+112.56%
  • Max+228.96%
See every congressional and insider trade on the NVS price chart

Quiver Premium charts NVS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 141.26 141.80 140.00 141.28 141.28 1,544,044
Sep 21, 2026 141.96 142.18 140.96 140.98 140.98 1,554,267
Sep 18, 2026 140.87 141.15 139.60 140.37 140.37 2,247,928
Sep 17, 2026 140.12 141.21 139.97 140.92 140.92 1,713,985
Sep 16, 2026 140.58 141.46 138.28 138.70 138.70 1,891,750
Sep 15, 2026 138.76 139.11 137.37 138.62 138.62 2,367,107
Sep 14, 2026 141.64 141.64 138.99 138.99 138.99 2,479,927
Sep 11, 2026 139.31 139.55 137.00 137.16 137.16 2,353,807
Sep 10, 2026 138.76 139.43 137.46 137.48 137.48 2,419,869
Sep 9, 2026 138.14 139.45 137.30 137.48 137.48 2,937,132
Sep 8, 2026 139.94 140.46 137.12 137.70 137.70 10,273,933
Sep 4, 2026 159.90 160.93 159.62 159.99 159.99 1,294,324
Sep 3, 2026 164.48 164.48 161.42 163.09 163.09 2,453,140
Sep 2, 2026 160.80 163.18 160.38 162.46 162.46 4,344,101
Sep 1, 2026 162.15 163.57 160.21 161.25 161.25 4,334,983
Aug 31, 2026 152.60 152.74 151.69 152.06 152.06 1,286,181
Aug 28, 2026 154.51 154.56 152.77 153.81 153.81 1,165,888
Aug 27, 2026 155.93 155.93 154.43 154.65 154.65 1,220,734
Aug 26, 2026 158.41 159.19 157.44 157.54 157.54 1,473,550
Aug 25, 2026 158.51 160.29 157.83 159.98 159.98 998,182
Aug 24, 2026 157.12 158.46 156.77 158.02 158.02 801,260
Aug 21, 2026 156.17 159.72 156.10 158.86 158.86 1,183,728
Aug 20, 2026 159.07 159.33 155.87 156.24 156.24 1,525,742
Aug 19, 2026 156.29 160.81 156.17 160.31 160.31 2,400,550
Aug 18, 2026 153.58 155.10 153.38 154.55 154.55 1,412,922
Aug 17, 2026 151.23 152.62 150.83 151.97 151.97 1,198,730
Aug 14, 2026 149.39 151.46 149.09 150.88 150.88 1,597,683
Aug 13, 2026 152.84 153.02 151.53 151.72 151.72 1,517,179
Aug 12, 2026 152.03 153.43 151.81 152.32 152.32 2,470,641
Aug 11, 2026 156.47 157.34 154.51 154.61 154.61 1,070,807
Aug 10, 2026 155.84 156.93 155.39 156.79 156.79 995,478
Aug 7, 2026 156.56 156.68 155.38 156.33 156.33 1,309,131
Aug 6, 2026 155.58 155.88 153.67 154.21 154.21 1,045,448
Aug 5, 2026 155.23 155.56 153.81 154.44 154.44 1,177,802
Aug 4, 2026 154.89 154.89 152.99 153.27 153.27 1,706,548
Aug 3, 2026 155.66 156.37 153.02 153.67 153.67 1,666,572
Jul 31, 2026 156.99 157.12 155.03 156.15 156.15 1,546,279
Jul 30, 2026 156.91 158.55 156.46 158.44 158.44 2,086,787
Jul 29, 2026 159.15 159.37 157.32 158.83 158.83 1,627,202
Jul 28, 2026 158.07 160.34 158.03 159.85 159.85 1,689,946
Jul 27, 2026 156.59 158.08 155.79 156.11 156.11 1,620,400
Jul 24, 2026 156.11 156.38 154.44 155.01 155.01 1,826,639
Jul 23, 2026 151.71 156.94 151.44 156.14 156.14 2,105,475
Jul 22, 2026 156.07 156.41 152.67 153.08 153.08 1,458,913
Jul 21, 2026 155.39 159.30 153.66 153.87 153.87 2,654,214
Jul 20, 2026 153.17 153.54 149.33 149.56 149.56 1,841,361
Jul 17, 2026 153.97 155.30 153.13 153.76 153.76 2,592,816
Jul 16, 2026 150.48 153.18 150.21 152.73 152.73 2,368,258
Jul 15, 2026 150.02 151.66 149.65 150.80 150.80 1,757,763
Jul 14, 2026 152.08 152.44 150.33 150.36 150.36 1,239,870
Jul 13, 2026 152.68 154.17 151.94 153.37 153.37 1,177,435
Jul 10, 2026 154.80 155.00 153.63 154.05 154.05 1,165,696
Jul 9, 2026 154.90 155.47 153.79 154.62 154.62 2,270,450
Jul 8, 2026 155.26 156.40 155.10 155.17 155.17 1,420,131
Jul 7, 2026 157.15 157.93 156.43 157.03 157.03 1,445,023
Jul 6, 2026 157.32 157.57 154.21 155.49 155.49 1,918,302
Jul 2, 2026 157.50 160.57 157.00 159.90 159.90 1,588,015
Jul 1, 2026 154.67 155.02 153.22 154.14 154.14 1,917,955
Jun 30, 2026 157.63 157.89 155.92 156.72 156.72 1,755,153
Jun 29, 2026 156.14 157.73 155.79 157.59 157.59 2,315,161
Jun 26, 2026 153.33 156.38 153.33 155.41 155.41 3,831,260
Jun 25, 2026 153.47 155.84 153.41 155.12 155.12 4,445,153
Jun 24, 2026 154.20 154.96 152.31 153.12 153.12 7,223,545
Jun 23, 2026 151.94 153.47 151.35 153.38 153.38 1,403,616
Jun 22, 2026 146.94 149.23 146.60 148.93 148.93 1,399,965
Jun 18, 2026 149.90 150.08 146.92 147.08 147.08 1,869,631
Jun 17, 2026 151.42 152.57 150.20 150.88 150.88 1,664,884
Jun 16, 2026 150.46 151.38 148.64 150.93 150.93 1,589,302
Jun 15, 2026 153.07 153.32 151.26 151.56 151.56 1,683,510
Jun 12, 2026 153.93 154.22 152.85 153.07 153.07 1,178,040
Jun 11, 2026 152.00 154.71 151.62 153.92 153.92 2,128,732
Jun 10, 2026 149.03 149.72 147.91 148.12 148.12 1,437,031
Jun 9, 2026 147.19 149.71 147.04 149.12 149.12 2,418,942
Jun 8, 2026 147.54 148.53 146.39 146.42 146.42 2,591,967
Jun 5, 2026 147.65 149.16 147.44 149.16 149.16 3,570,679
Jun 4, 2026 146.46 148.48 146.46 148.40 148.40 2,489,180
Jun 3, 2026 142.47 144.25 142.26 143.66 143.66 1,538,154
Jun 2, 2026 144.01 144.46 142.64 143.48 143.48 1,473,008
Jun 1, 2026 146.92 147.50 144.72 145.68 145.68 2,052,759
May 29, 2026 151.84 152.03 150.12 150.17 150.17 1,635,433
May 28, 2026 150.13 151.74 149.96 151.40 151.40 1,643,104
May 27, 2026 151.05 152.37 150.62 151.12 151.12 989,019
May 26, 2026 152.30 152.49 150.31 150.80 150.80 1,047,357
May 22, 2026 151.56 152.54 151.24 152.01 152.01 1,410,578
May 21, 2026 150.09 152.52 149.54 151.76 151.76 965,765
May 20, 2026 150.95 151.76 150.23 150.45 150.45 1,362,929
May 19, 2026 149.61 151.41 149.32 150.44 150.44 999,095
May 18, 2026 149.01 150.58 148.94 149.15 149.15 1,083,235
May 15, 2026 150.12 150.33 147.81 148.08 148.08 829,343
May 14, 2026 150.13 150.56 148.60 149.77 149.77 1,521,780
May 13, 2026 148.23 150.32 148.16 149.75 149.75 1,271,464
May 12, 2026 146.29 148.56 145.88 148.16 148.16 921,781
May 11, 2026 146.59 147.28 144.75 145.23 145.23 2,098,902
May 8, 2026 146.45 146.67 145.48 146.03 146.03 1,067,499
May 7, 2026 147.97 148.06 144.99 145.39 145.39 1,005,070
May 6, 2026 147.80 148.76 147.51 148.36 148.36 1,115,578
May 5, 2026 146.62 146.65 144.79 145.50 145.50 1,328,707
May 4, 2026 145.55 145.82 144.45 144.62 144.62 1,720,723
May 1, 2026 148.13 148.13 146.35 146.57 146.57 1,094,463
Apr 30, 2026 146.51 148.58 146.22 147.85 147.85 1,402,485
Apr 29, 2026 143.05 144.04 142.25 142.94 142.94 1,612,454
Apr 28, 2026 144.26 145.65 142.65 145.50 145.50 2,650,599
Apr 27, 2026 144.67 145.71 144.12 144.19 144.19 1,604,270
Apr 24, 2026 146.03 146.07 144.05 145.47 145.47 1,299,765
Apr 23, 2026 147.88 148.36 146.58 147.48 147.48 1,687,480
Apr 22, 2026 148.58 148.58 147.12 147.32 147.32 1,026,370
Apr 21, 2026 149.61 149.62 147.77 147.97 147.97 2,117,579
Apr 20, 2026 151.40 152.04 150.77 150.99 150.99 1,229,057
Apr 17, 2026 151.55 152.54 150.75 151.97 151.97 1,070,262
Apr 16, 2026 150.38 150.86 149.38 149.73 149.73 1,066,063
Apr 15, 2026 153.98 154.10 150.86 152.08 152.08 1,097,303
Apr 14, 2026 154.03 155.04 153.33 153.38 153.38 1,257,017
Apr 13, 2026 153.72 154.50 152.90 154.47 154.47 841,528
Apr 10, 2026 156.46 156.46 153.70 154.05 154.05 997,057
Apr 9, 2026 152.76 156.12 152.48 155.06 155.06 906,107
Apr 8, 2026 153.77 154.45 152.71 154.42 154.42 2,118,090
Apr 7, 2026 151.44 151.49 149.49 151.22 151.22 2,024,090
Apr 6, 2026 153.59 154.36 152.84 152.84 152.84 1,185,394
Apr 2, 2026 153.37 154.81 153.16 154.03 154.03 2,630,988
Apr 1, 2026 154.62 156.08 154.12 155.08 155.08 1,626,855
Mar 31, 2026 151.58 152.86 150.51 152.75 152.75 2,003,399
Mar 30, 2026 150.25 150.75 149.56 150.36 150.36 2,078,278
Mar 27, 2026 150.01 150.60 147.85 148.18 148.18 1,983,841
Mar 26, 2026 149.67 151.11 149.31 149.70 149.70 1,157,614
Mar 25, 2026 150.47 151.78 150.15 150.75 150.75 1,214,843
Mar 24, 2026 146.56 148.98 146.22 148.61 148.61 1,198,193
Mar 23, 2026 147.21 148.95 146.90 148.09 148.09 1,648,410
Mar 20, 2026 148.77 148.90 145.29 146.03 146.03 2,019,872
Mar 19, 2026 147.81 149.32 147.15 148.19 148.19 2,370,768
Mar 18, 2026 152.38 152.76 149.47 149.81 149.81 1,605,427
Mar 17, 2026 155.64 155.79 154.38 154.85 154.85 2,220,490
Mar 16, 2026 154.54 155.38 153.85 154.87 154.87 2,512,357
Mar 13, 2026 154.69 155.96 153.18 153.44 153.44 1,976,945
Mar 12, 2026 154.55 155.04 153.69 154.25 154.25 1,962,830
Mar 11, 2026$3.102 dividend 155.99 156.58 154.96 155.80 155.80 5,153,837
Mar 10, 2026 161.35 163.07 160.43 161.59 158.44 3,705,722
Mar 9, 2026 159.52 163.08 159.22 162.79 159.61 1,751,860
Mar 6, 2026 156.71 160.54 156.18 160.12 156.99 3,765,304
Mar 5, 2026 161.05 161.39 158.95 161.01 157.87 4,320,242
Mar 4, 2026 164.44 165.69 162.19 165.15 161.93 2,135,204
Mar 3, 2026 162.43 164.89 160.42 164.18 160.97 3,225,614
Mar 2, 2026 167.16 167.61 165.79 166.87 163.61 2,811,560
Feb 27, 2026 169.11 170.46 168.56 168.62 165.33 3,195,749
Feb 26, 2026 166.73 166.90 164.27 165.51 162.28 4,185,840
Feb 25, 2026 167.19 168.02 166.75 166.85 163.59 3,771,871
Feb 24, 2026 166.10 167.84 166.10 167.11 163.85 3,315,188
Feb 23, 2026 163.66 165.64 163.66 164.70 161.48 1,970,738
Feb 20, 2026 162.67 163.63 161.75 162.67 159.49 2,059,765
Feb 19, 2026 163.87 164.02 162.53 163.92 160.72 1,836,350
Feb 18, 2026 167.57 167.86 164.71 165.38 162.15 2,379,635
Feb 17, 2026 166.78 167.29 165.57 166.17 162.93 2,508,793
Feb 13, 2026 162.16 163.42 161.79 163.10 159.92 1,877,046
Feb 12, 2026 159.60 162.32 159.47 161.18 158.03 2,337,635
Feb 11, 2026 159.25 160.18 158.04 160.06 156.94 2,720,451
Feb 10, 2026 158.50 159.37 157.46 158.20 155.11 4,086,454
Feb 9, 2026 156.98 157.57 155.94 157.05 153.98 2,435,959
Feb 6, 2026 154.03 156.62 153.90 156.42 153.37 3,011,993
Feb 5, 2026 152.00 154.95 151.68 153.95 150.94 4,100,282
Feb 4, 2026 153.82 154.71 151.41 152.91 149.93 4,379,959
Feb 3, 2026 149.68 151.53 149.38 149.86 146.93 3,522,474
Feb 2, 2026 149.63 151.31 149.54 151.04 148.09 1,843,177
Jan 30, 2026 149.49 149.98 148.13 148.68 145.78 1,147,269
Jan 29, 2026 148.62 149.53 148.34 148.91 146.00 1,588,817
Jan 28, 2026 148.71 149.39 146.84 147.87 144.98 1,990,013
Jan 27, 2026 150.64 152.48 150.49 152.22 149.25 3,393,337
Jan 26, 2026 148.29 150.13 147.99 149.12 146.21 1,719,749
Jan 23, 2026 145.61 148.10 145.26 147.14 144.27 1,823,885
Jan 22, 2026 144.73 146.22 144.45 145.00 142.17 1,139,689
Jan 21, 2026 143.82 145.22 143.43 145.11 142.28 2,027,491
Jan 20, 2026 144.00 144.85 142.82 143.58 140.78 1,827,954
Jan 16, 2026 143.78 144.76 142.89 144.34 141.52 1,651,568
Jan 15, 2026 145.07 145.07 142.26 143.15 140.35 1,036,310
Jan 14, 2026 144.56 146.35 144.29 146.16 143.31 1,844,822
Jan 13, 2026 142.37 142.59 140.79 141.61 138.84 2,107,067
Jan 12, 2026 142.98 143.00 140.31 141.82 139.05 1,502,176
Jan 9, 2026 141.99 142.90 141.46 141.54 138.78 1,117,558
Jan 8, 2026 142.55 143.48 140.85 141.46 138.70 1,560,280
Jan 7, 2026 141.67 143.49 141.16 141.98 139.21 2,003,436
Jan 6, 2026 139.09 142.58 139.09 142.27 139.49 3,285,893
Jan 5, 2026 137.13 137.96 135.55 137.91 135.22 1,232,693
Jan 2, 2026 138.28 138.56 137.02 138.54 135.84 1,039,776
Dec 31, 2025 138.71 138.91 137.80 137.87 135.18 756,336
Dec 30, 2025 138.76 139.12 138.41 138.72 136.01 710,477
Dec 29, 2025 138.86 139.45 138.84 139.20 136.48 777,557
Dec 26, 2025 138.88 139.22 138.39 139.18 136.46 587,168
Dec 24, 2025 139.06 139.48 138.53 138.88 136.17 646,982
Dec 23, 2025 139.60 140.18 138.78 139.13 136.41 1,945,618
Dec 22, 2025 136.48 137.27 136.00 136.87 134.20 1,388,693
Dec 19, 2025 134.94 137.16 134.82 136.06 133.40 1,392,569
Dec 18, 2025 135.19 135.69 134.88 135.27 132.63 1,544,509
Dec 17, 2025 135.34 137.40 134.96 135.03 132.39 2,458,304
Dec 16, 2025 136.66 136.66 134.40 135.03 132.39 1,721,430
Dec 15, 2025 133.90 135.27 133.67 135.19 132.55 1,635,681
Dec 12, 2025 132.37 133.01 131.77 132.57 129.98 1,226,073
Dec 11, 2025 132.46 133.84 132.20 132.36 129.78 2,062,573
Dec 10, 2025 131.05 131.63 130.46 131.19 128.63 2,068,214
Dec 9, 2025 132.55 133.16 130.81 131.01 128.45 2,127,869
Dec 8, 2025 132.83 132.85 129.98 130.17 127.63 2,245,497
Dec 5, 2025 133.82 134.04 132.09 132.16 129.58 1,997,207
Dec 4, 2025 133.63 133.95 132.18 132.43 129.84 1,266,401
Dec 3, 2025 133.62 134.24 133.43 133.72 131.11 1,259,783
Dec 2, 2025 131.55 132.67 130.73 132.28 129.70 1,943,615
Dec 1, 2025 131.02 131.15 128.91 128.97 126.45 1,603,404
Nov 28, 2025 130.21 130.51 129.43 130.40 127.85 1,514,183
Nov 26, 2025 130.16 131.19 129.85 130.44 127.89 1,312,012
Nov 25, 2025 128.75 130.47 128.75 130.26 127.72 2,017,811
Nov 24, 2025 127.44 128.14 126.50 126.54 124.07 1,712,284
Nov 21, 2025 125.88 127.89 125.88 127.31 124.82 2,200,346
Nov 20, 2025 125.63 125.63 123.24 124.36 121.93 2,417,187
Nov 19, 2025 128.21 128.40 126.31 127.31 124.82 1,716,185
Nov 18, 2025 127.83 128.70 126.94 128.01 125.51 2,003,165
Nov 17, 2025 132.39 133.19 131.46 131.55 128.98 1,743,994
Nov 14, 2025 132.46 132.76 130.30 131.26 128.70 1,822,809
Nov 13, 2025 131.88 134.00 131.81 131.91 129.34 1,603,682
Nov 12, 2025 130.92 132.30 130.80 132.29 129.71 1,290,571
Nov 11, 2025 128.81 130.69 128.72 130.50 127.95 1,594,547
Nov 10, 2025 126.69 127.28 126.29 127.20 124.72 1,224,653
Nov 7, 2025 126.47 126.96 126.00 126.35 123.88 1,417,688
Nov 6, 2025 126.27 127.11 126.06 126.57 124.10 1,119,515
Nov 5, 2025 124.53 125.92 124.47 125.50 123.05 1,260,159
Nov 4, 2025 123.51 125.46 123.51 125.01 122.57 1,509,998
Nov 3, 2025 123.08 124.05 122.86 123.86 121.44 1,657,148
Oct 31, 2025 123.41 124.15 122.57 123.79 121.37 1,655,479
Oct 30, 2025 122.65 123.33 121.98 122.61 120.22 2,358,730
Oct 29, 2025 123.29 123.92 121.57 121.80 119.42 2,582,655
Oct 28, 2025 125.52 125.75 123.06 123.43 121.02 4,631,015
Oct 27, 2025 128.00 130.17 127.08 129.14 126.62 2,578,941
Oct 24, 2025 131.53 131.54 130.28 130.36 127.81 1,219,978
Oct 23, 2025 130.82 131.68 130.62 131.64 129.07 1,670,562
Oct 22, 2025 131.06 132.33 131.06 131.43 128.86 1,029,014
Oct 21, 2025 131.33 131.77 130.88 131.34 128.78 734,770
Oct 20, 2025 131.41 132.21 130.60 131.79 129.22 1,382,550
Oct 17, 2025 130.57 132.44 130.41 131.43 128.86 1,326,320
Oct 16, 2025 129.88 131.19 129.65 130.77 128.22 1,169,096
Oct 15, 2025 128.24 130.41 128.18 129.97 127.43 1,454,399
Oct 14, 2025 129.57 130.49 129.32 130.26 127.72 1,559,377
Oct 13, 2025 129.62 130.01 128.83 129.12 126.60 1,994,578
Oct 10, 2025 131.82 131.87 129.93 130.03 127.49 2,289,641
Oct 9, 2025 132.60 132.91 130.99 131.06 128.50 1,657,803
Oct 8, 2025 132.71 133.16 132.26 132.31 129.73 3,142,176
Oct 7, 2025 132.12 132.55 131.32 131.55 128.98 942,428
Oct 6, 2025 132.26 133.55 132.06 132.25 129.67 1,376,813
Oct 3, 2025 132.24 133.37 131.95 132.39 129.81 1,415,447
Oct 2, 2025 131.02 131.52 129.97 130.97 128.41 1,712,983
Oct 1, 2025 129.00 131.96 128.94 131.72 129.15 3,358,714
Sep 30, 2025 123.89 128.51 123.83 128.24 125.74 2,188,928
Sep 29, 2025 123.35 124.60 123.20 124.10 121.68 1,217,298
Sep 26, 2025 123.00 123.86 122.78 123.65 121.24 915,203
Sep 25, 2025 123.97 124.14 122.21 122.23 119.84 1,400,424
Sep 24, 2025 122.53 123.31 122.37 123.00 120.60 691,986
Sep 23, 2025 122.99 123.40 122.53 122.82 120.42 754,964
Sep 22, 2025 123.50 124.01 123.19 123.36 120.95 992,461

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Novartis AG Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NVS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation